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PHA405 – Therapeutics A 
DURATION 
 
Reading Time: 10 minutes 
Writing Time: 180 minutes 
 
INSTRUCTIONS TO CANDIDATES 
The exam consists of 2 Sections (A & B).  
Section A (1-60): 60 marks.  Please circle the correct answer on the question paper for this 
section. There is one correct answer for each question.  You can use a pencil to circle the 
answers initially just in case you need to change them, but at the end of the exam, all your final 
answers should be circled using a pen. 
Section B (1-8): 40 marks.  It should be answered in the 20-page booklet provided.  Ensure that 
your name and student number have been written on the front page of the answer booklet. 
 
Total marks of the exam: 100 marks 
EXAM CONDITIONS 
You may begin writing from the commencement of the examination session.  The reading time indicated above is 
provided as a guide only. 
This is a CLOSED BOOK examination 
No calculator is permitted 
No handwritten notes are permitted 
No dictionaries are permitted 
ADDITIONAL AUTHORISED MATERIALS EXAMINATION MATERIALS TO BE SUPPLIED 
 




1 x 20 Page Book 
1 x Scrap Paper 
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Multiple Choice Questions 
Total No. of Marks for this Section: 60 
Please circle the correct answer on the question paper for this section. There is one correct answer 
for each question.  You can use a pencil to circle the answers initially just in case you need to 
change them, but at the end of the exam, all your final answers should be circled using a pen. 







 Semester 1, 2019 FINAL EXAMINATION Page 4 of 5  
PHA405 – Therapeutics A 
 
THIS EXAMINATION PAPER AND SUPPLIED MATERIALS ARE NOT PERMITTED TO BE REMOVED FROM ANY EXAMINATION VENUE IN ANY 




Total No. of Marks for this Section: 40 
Please answer this section in the 20-page Answer Booklet provided.  Ensure that your name and 
student number have been written on the front page of the answer booklet. 
Answer all EIGHT (8) questions. 
Marks for each question are indicated.  
 
Question 1 
There are four compensatory mechanisms activated in heart failure.  What are the beneficial and 
detrimental effects of these compensatory mechanisms?  




Counsel a patient about how to use glyceryl trinitrate spray.  Include in your answer the 
precautions when using this device. 
  (5 marks) 
 
 
Question 3  
Describe the main characteristics of anginal chest pain. 




What is the definition of hypoglycaemia? What are the signs? How should it be managed? 
  (6 marks) 
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In relation to the emergency management of a suspected case of acute coronary syndrome, what 
does “MONA” stand for? Comment on the purpose of “MONA”. 




“Triple Whammy” is a significant drug interaction.  Comment on the types of agents involved in this 
interaction and the mechanism (i.e. how it occurs). 
  (5 marks) 
 
 
Question 7  
What measures should be taken to prevent contrast-induced nephropathy?  




Counsel a patient about the correct use of salbutamol inhaler.  Include in your answer the 
precautions when using this device. 





End of Section B 
 
 
End of Exam Paper 
 
